PPAR Agonist-Induced Reduction of Mcp1 in Atherosclerotic Plaques of Obese, Insulin-Resistant Mice Depends on Adiponectin-Induced Irak3 Expression

Role of Adiponectin in the Metabolic Syndrome: Current Perspectives on its Modulation as a Treatment Strategy

(2013) Indira Padmalayam et al.   CURRENT PHARMACEUTICAL DESIGN

Endogenous IRAK-M Attenuates Postinfarction Remodeling Through Effects on Macrophages and Fibroblasts

(2012) Wei Chen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Central leptin and insulin administration modulates serum cytokine- and lipoprotein-related markers

(2012) Emma Burgos-Ramos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Obesity, inflammation and the immune system

(2012) Fátima Pérez de Heredia et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

PPAR  attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells

(2011) L.-L. Zhang et al.   CARDIOVASCULAR RESEARCH

Adiponectin Is Required for PPARγ-Mediated Improvement of Endothelial Function in Diabetic Mice

(2011) Wing Tak Wong et al.   Cell Metabolism

TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth

(2011) T J Standiford et al.   ONCOGENE

Evaluation of anti-atherosclerotic activities of PPAR-α, PPAR-γ, and LXR agonists in hyperlipidemic atherosclerosis-susceptible F1B hamsters

(2010) Rai Ajit K. Srivastava   ATHEROSCLEROSIS

Adiponectin

(2009) Ling Tao et al.   CIRCULATION RESEARCH

Stevioside inhibits atherosclerosis by improving insulin signaling and antioxidant defense in obese insulin-resistant mice

(2009) B Geeraert et al.   INTERNATIONAL JOURNAL OF OBESITY

Adiponectin Promotes Endotoxin Tolerance in Macrophages by Inducing IRAK-M Expression

(2009) Vassiliki Zacharioudaki et al.   JOURNAL OF IMMUNOLOGY

Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus

(2008) N. P. E. Kadoglou et al.   DIABETIC MEDICINE

Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice

(2007) W Verreth et al.   BRITISH JOURNAL OF PHARMACOLOGY